TF
FBIO icon

TME Financial’s Fortress Biotech FBIO Stock Holding History

TME Financial’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,500
Closed -$42.5K – 76
2025
Q3 		$42.5K Hold
11,500
– – 0.03% 74
2025
Q2 		$21.4K Hold
11,500
– – 0.02% 74
2025
Q1 		$17.9K Buy
+11,500
New +$20.3K 0.02% 72

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

TME Financial's FBIO Position: Q4 2025 in Review

TME Financial sold out of Fortress Biotech (FBIO) in Q4 2025, closing a stake of 11,500 shares — an estimated $42.5K sold.

TME Financial first reported a position in FBIO in Q1 2025 and held it in 3 quarters. The position peaked at $42.5K in Q3 2025. 52 funds tracked by Wall St. Rank hold FBIO as of Q4 2025.

  • TME Financial reported no remaining Fortress Biotech position as of Q4 2025 after selling out during the quarter.
  • TME Financial sold 11,500 Fortress Biotech shares in Q4 2025, an estimated $42.5K.
  • TME Financial first reported a position in Fortress Biotech in Q1 2025 and held it in 3 quarters.
  • TME Financial's Fortress Biotech position peaked at $42.5K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2025.

Based on TME Financial's 13F filing for Q4 2025, filed 27 Jan 2026.